{"id":"alveofact","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T05:53:37.119Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06367881","phase":"PHASE1","title":"Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2022-08-18","conditions":"Neonatal Respiratory Distress Syndrome, Inflammatory Response, Premature Lungs","enrollment":60},{"nctId":"NCT04086095","phase":"NA","title":"Feasibility Study - Neofact","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2019-05-13","conditions":"Respiratory Distress Syndrome in Premature Infant, Surfactant Deficiency Syndrome Neonatal","enrollment":20},{"nctId":"NCT02985437","phase":"PHASE1","title":"Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin","status":"COMPLETED","sponsor":"Prof. Dr. Dr. Ursula Mirastschijski","startDate":"2016-12-08","conditions":"Skin and Connective Tissue Diseases","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":93,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_1","status":"active","brandName":"Alveofact","genericName":"Alveofact","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}